Founded in 1946 to develop and market the inventions of Dr. David B. Pall, the company’s originator, today Pall Corporation is a global leader in the high-tech filtration, separation and purification industry. We began developing solutions for the life sciences segment in the 1970s, and have built an industry-leading portfolio of downstream technologies, which we’ve proudly exhibited at INTERPHEX for many years.
With the recent acquisitions of Medistad Holding BV, SoloHill Engineering, Inc. and the LifeSciences business of ATMI, we can now offer our customers an expanded suite of solutions covering both upstream and downstream requirements at all processing scales. The moves also give us one of the strongest and most complete portfolios in the single-use space. Our newly extended capabilities will be showcased for the first time at INTERPHEX 2014. We look forward to connecting with industry colleagues in person to discuss our growing portfolio in more detail.
In the meantime, here’s a sneak peek at our new offerings. The acquisition of ATMI’s LifeSciences business adds custom-engineered, flexible packaging solutions, single-use storage systems, mixers and bioreactors for pharmaceutical and biopharmaceutical applications. The addition of SoloHill gives us leadership in microcarrier beads that can be used in single-use bioreactors. And Medistad brings specialized single-use systems engineering capabilities.
The expanded Pall team will be on-site at INTERPHEX 2014 in booths 3021 and 3341. The team can guide you through our multiple solutions for single-use applications. Please visit at your leisure.
Looking forward to seeing you in New York!
President, Pall Biopharmaceuticals